Global Cancer Targeted Therapy Industry 2015 Deep Market Research Report

Global Cancer Targeted Therapy Industry 2015 Deep Market Research Report

Category : Pharmaceuticals
Published On : November  2015
Pages : 122



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
The Global Cancer Targeted Therapy Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Cancer Targeted Therapy industry.

The report provides a basic overview of the industry including definitions and classifications. The Cancer Targeted Therapy market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information. 

With 136 the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview
1.1 Basic Information of Cancer Targeted Therapy
1.1.1 Definition of Cancer Targeted Therapy
1.1.2 Classifications of Cancer Targeted Therapy
1.1.2.1 Tumor Antigens as Targets of Antibodies
1.1.2.2 Development of Antibodies for Clinical Purposes
1.1.2.3 Complement Dependent Cytotoxicity (CDC)
1.1.2.4 Signal Transduction Changes
1.1.3 Applications of Cancer Targeted Therapy
1.1.4 Characteristics of Cancer Targeted Therapy
1.2 Development Overview of Cancer Targeted Therapy
1.3 Enter Barriers Analysis of Cancer Targeted Therapy

2 Cancer Targeted Therapy International and China Market Analysis
2.1 Cancer Targeted Therapy Industry International Market Analysis
2.1.1 Cancer Targeted Therapy International Market Development History
2.1.2 Cancer Targeted Therapy Competitive Landscape Analysis
2.1.3 Cancer Targeted Therapy International Main Countries Development Status
2.1.4 Cancer Targeted Therapy International Market Development Trend
2.2 Cancer Targeted Therapy Industry China Market Analysis
2.2.1 Cancer Targeted Therapy China Market Development History
2.2.2 Cancer Targeted Therapy Competitive Landscape Analysis
2.2.3 Cancer Targeted Therapy China Main Regions Development Status
2.2.4 Cancer Targeted Therapy China Market Development Trend
2.3 Cancer Targeted Therapy International and China Market Comparison Analysis

3 Environment Analysis of Cancer Targeted Therapy
3.1 International Economy Analysis
3.2 China Economy Analysis
3.3 Policy Analysis of Cancer Targeted Therapy
3.4 News Analysis of Cancer Targeted Therapy

4 Analysis of Revenue by Classifications
4.1 Global Revenue of Cancer Targeted Therapy by Classifications 2010-2015
4.2 Global Revenue Growth Rate of Cancer Targeted Therapy by Classifications 2010-2015
4.3 Cancer Targeted Therapy Revenue by Classifications

5 Analysis of Revenue by Regions and Applications
5.1 Global Revenue of Cancer Targeted Therapy by Regions 2010-2015
5.2 2010-2015 USA Revenue and Revenue Growth Rate of Cancer Targeted Therapy
5.3 2010-2015 Europe Revenue and Revenue Growth Rate of Cancer Targeted Therapy
5.4 2010-2015 Japan Revenue and Revenue Growth Rate of Cancer Targeted Therapy
5.5 2010-2015 China Revenue and Revenue Growth Rate of Cancer Targeted Therapy

6 Analysis of Cancer Targeted Therapy Revenue Market Status 2010-2015
6.1 Revenue of Cancer Targeted Therapy 2010-2015
6.2 Revenue Market Share Analysis of Cancer Targeted Therapy 2010-2015
6.3 Revenue Overview of Cancer Targeted Therapy 2010-2015
6.4 Gross Margin of Cancer Targeted Therapy 2010-2015

7 Analysis of Cancer Targeted Therapy Industry Key Manufacturers
7.1 Advaxis
7.1.1 Company Profile
7.1.2 Revenue and Gross Margin
7.1.3 Advaxis SWOT Analysis

7.2 Bind Therapeutics
7.2.1 Company Profile
7.2.2 Revenue and Gross Margin
7.2.3 Bind Therapeutics SWOT Analysis

7.3 Boehringer Ingelheim
7.3.1 Company Profile
7.3.2 Revenue and Gross Margin
7.3.3 Boehringer Ingelheim SWOT Analysis

7.4 Bristol Mayer Squibb
7.4.1 Company Profile
7.4.2 Revenue and Gross Margin
7.4.3 Bristol Mayer Squibb SWOT Analysis

7.5 Celldex Therapeutics
7.5.1 Company Profile
7.5.2 Revenue and Gross Margin
7.5.3 Celldex Therapeutics SWOT Analysis

7.6 Dendreon Corporation
7.6.1 Company Profile
7.6.2 Revenue and Gross Margin
7.6.3 Dendreon Corporation SWOT Analysis

7.7 Eli Lily
7.7.1 Company Profile
7.7.2 Revenue and Gross Margin
7.7.3 Eli Lily SWOT Analysis

7.8 GalaxoSmithKline
7.8.1 Company Profile
7.8.2 Revenue and Gross Margin
7.8.3 GalaxoSmithKline SWOT Analysis

7.9 Galena Biopharma
7.9.1 Company Profile
7.9.2 Revenue and Gross Margin
7.9.3 Galena Biopharma SWOT Analysis

7.10 Genetech
7.10.1 Company Profile
7.10.2 Revenue and Gross Margin
7.10.3 Genetech SWOT Analysis

7.11 ImmunoCellular Therapeutics
7.11.1 Company Profile
7.11.2 Revenue and Gross Margin
7.11.3 ImmunoCellular Therapeutics SWOT Analysis

7.12 ImmunoGen
7.12.1 Company Profile
7.12.2 Revenue and Gross Margin
7.12.3 ImmunoGen SWOT Analysis

7.13 Inovio Pharmaceuticals
7.13.1 Company Profile
7.13.2 Revenue and Gross Margin
7.13.3 Inovio Pharmaceuticals SWOT Analysis

7.14 Johnson & Johnson
7.14.1 Company Profile
7.14.2 Revenue and Gross Margin
7.14.3 Johnson & Johnson SWOT Analysis

7.15 NeoStem Oncology
7.15.1 Company Profile
7.15.2 Revenue and Gross Margin
7.15.3 NeoStem Oncology SWOT Analysis

7.16 NewLink Genetics
7.16.1 Company Profile
7.16.2 Revenue and Gross Margin
7.16.3 NewLink Genetics SWOT Analysis

7.17 Northwest Biotherapeutics
7.17.1 Company Profile
7.17.2 Revenue and Gross Margin
7.17.3 Northwest Biotherapeutics SWOT Analysis

7.18 Merck
7.18.1 Company Profile
7.18.2 Revenue and Gross Margin
7.18.3 Merck SWOT Analysis

7.19 Novartis
7.19.1 Company Profile
7.19.2 Revenue and Gross Margin
7.19.3 Novartis SWOT Analysis

7.20 Peregrine Pharmaceuticals
7.20.1 Company Profile
7.20.2 Revenue and Gross Margin
7.20.3 Peregrine Pharmaceuticals SWOT Analysis

7.21 Pfizer
7.21.1 Company Profile
7.21.2 Revenue and Gross Margin
7.21.3 Pfizer SWOT Analysis

7.22 Roche
7.22.1 Company Profile
7.22.2 Revenue and Gross Margin
7.22.3 Roche SWOT Analysis

7.23 Sanofi
7.23.1 Company Profile
7.23.2 Revenue and Gross Margin
7.23.3 Sanofi SWOT Analysis

7.24 Seattle Genetics
7.24.1 Company Profile
7.24.2 Revenue and Gross Margin
7.24.3 Seattle Genetics SWOT Analysis

7.25 Teva
7.25.1 Company Profile
7.25.2 Revenue and Gross Margin
7.25.3 Teva SWOT Analysis

8 Sales Price and Gross Margin Analysis
8.1 Sales Price Analysis of Cancer Targeted Therapy
8.2 Gross Margin Analysis of Cancer Targeted Therapy

9 Marketing Trader or Distributor Analysis of Cancer Targeted Therapy
9.1 Marketing Channels Status of Cancer Targeted Therapy
9.2 How Countries Meet Their Needs
9.2.1 USA
9.2.2 China
9.2.3 Japan
9.2.4 Germany

10 Development Trend of Cancer Targeted Therapy Industry 2016-2021
10.1 Revenue Overview of Cancer Targeted Therapy 2016-2021
10.2 Sales Price Overview of Cancer Targeted Therapy 2016-2021

11 Industry Chain Suppliers of Cancer Targeted Therapy with Contact Information
11.1 Equipment Suppliers of Cancer Targeted Therapy with Contact Information
11.2 Major Suppliers of Cancer Targeted Therapy with Contact Information
11.3 Key Consumers of Cancer Targeted Therapy with Contact Information
11.4 Supply Chain Relationship Analysis of Cancer Targeted Therapy

12 New Project Investment Feasibility Analysis of Cancer Targeted Therapy
12.1 New Project SWOT Analysis of Cancer Targeted Therapy
12.2 New Project Investment Feasibility Analysis of Cancer Targeted Therapy

13 Conclusion of the Global Cancer Targeted Therapy Industry 2015 Deep Market Research Report


List of Tables and Figures
Table Classifications of Cancer Targeted Therapy
Table Applications of Cancer Targeted Therapy
Table Policy of Cancer Targeted Therapy
Table Industry News List of Cancer Targeted Therapy
Table Global Revenue of Cancer Targeted Therapy by Classifications 2010-2015 (M USD)
Table Global Revenue Market Share of Cancer Targeted Therapy by Classifications 2010-2015
Figure Global Revenue Market Share of Cancer Targeted Therapy by Classifications in 2010
Figure Global Revenue Market Share of Cancer Targeted Therapy by Classifications in 2015
Figure Global Revenue Growth Rate of Type One 2010-2015
Figure Global Revenue Growth Rate of Type Two 2010-2015
Figure Global Revenue Growth Rate of Type Three 2010-2015
Table USA Cancer Targeted Therapy Revenue by Classifications
Table Europe Cancer Targeted Therapy Revenue by Classifications
Table Japan Cancer Targeted Therapy Revenue by Classifications
Table China Cancer Targeted Therapy Revenue by Classifications
Table Global Revenue of Cancer Targeted Therapy by Regions 2010-2015 (M USD)
Table Global Revenue Market Share of Cancer Targeted Therapy by Regions 2010-2015
Figure Global Revenue Market Share of Cancer Targeted Therapy by Regions in 2010
Figure Global Revenue Market Share of Cancer Targeted Therapy by Regions in 2015
Table USA Cancer Targeted Therapy Revenue by Applications
Figure USA Cancer Targeted Therapy Revenue and Revenue Growth Rate
Table Europe Cancer Targeted Therapy Revenue by Applications
Figure Europe Cancer Targeted Therapy Revenue and Revenue Growth Rate
Table Japan Cancer Targeted Therapy Revenue by Applications
Figure Japan Cancer Targeted Therapy Revenue and Revenue Growth Rate
Table China Cancer Targeted Therapy Revenue by Applications
Figure China Cancer Targeted Therapy Revenue and Revenue Growth Rate
Table Global and China Major Players Cancer Targeted Therapy Revenue of 2010-2015 (M USD)
Table Global and China Major Players Cancer Targeted Therapy Revenue Market Share of 2010-2015
Table China Major Players Cancer Targeted Therapy Revenue of 2010-2015 (M USD)
Table China Major Players Cancer Targeted Therapy Revenue Market Share of 2010-2015
Figure Global Revenue Market Share of Major Cancer Targeted Therapy Players in 2010
Figure Global Revenue Market Share of Major Cancer Targeted Therapy Players in 2015
Figure China Revenue Market Share Major Cancer Targeted Therapy Players in 2010
Figure China Revenue Market Share Major Cancer Targeted Therapy Players in 2015
Figure Global Revenue and Growth Rate of Cancer Targeted Therapy 2010-2015
Figure China Revenue and Growth Rate of Cancer Targeted Therapy 2010-2015
Figure 2010-2015 Global and China Cancer Targeted Therapy Revenue Comparison
Table Cost of Global Cancer Targeted Therapy Major Players 2010-2015 (M USD)
Table Gross of Global Cancer Targeted Therapy Major Players 2010-2015 (M USD)
Table Gross Margin of Global Cancer Targeted Therapy Major Players 2010-2015
Figure Gross Margin of Global Cancer Targeted Therapy Major Players in 2014
Table Company Profile List of Advaxis
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Advaxis 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Advaxis 2010-2015
Table SWOT Analysis of Advaxis 2010-2015
Table Company Profile List of Bind Therapeutics
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Bind Therapeutics 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Bind Therapeutics 2010-2015
Table SWOT Analysis of Bind Therapeutics 2010-2015
Table Company Profile List of Boehringer Ingelheim
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Boehringer Ingelheim 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Boehringer Ingelheim 2010-2015
Table SWOT Analysis of Boehringer Ingelheim 2010-2015
Table Company Profile List of Bristol Mayer Squibb
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Bristol Mayer Squibb 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Bristol Mayer Squibb 2010-2015
Table SWOT Analysis of Bristol Mayer Squibb 2010-2015
Table Company Profile List of Celldex Therapeutics
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Celldex Therapeutics 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Celldex Therapeutics 2010-2015
Table SWOT Analysis of Celldex Therapeutics 2010-2015
Table Company Profile List of Dendreon Corporation
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Dendreon Corporation 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Dendreon Corporation 2010-2015
Table SWOT Analysis of Dendreon Corporation 2010-2015
Table Company Profile List of Eli Lily
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Eli Lily 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Eli Lily 2010-2015
Table SWOT Analysis of Eli Lily 2010-2015
Table Company Profile List of GalaxoSmithKline
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of GalaxoSmithKline 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of GalaxoSmithKline 2010-2015
Table SWOT Analysis of GalaxoSmithKline 2010-2015
Table Company Profile List of Galena Biopharma
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Galena Biopharma 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Galena Biopharma 2010-2015
Table SWOT Analysis of Galena Biopharma 2010-2015
Table Company Profile List of Genetech
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Genetech 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Genetech 2010-2015
Table SWOT Analysis of Genetech 2010-2015
Table Company Profile List of ImmunoCellular Therapeutics
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of ImmunoCellular Therapeutics 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of ImmunoCellular Therapeutics 2010-2015
Table SWOT Analysis of ImmunoCellular Therapeutics 2010-2015
Table Company Profile List of ImmunoGen
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of ImmunoGen 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of ImmunoGen 2010-2015
Table SWOT Analysis of ImmunoGen 2010-2015
Table Company Profile List of Inovio Pharmaceuticals
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Inovio Pharmaceuticals 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Inovio Pharmaceuticals 2010-2015
Table SWOT Analysis of Inovio Pharmaceuticals 2010-2015
Table Company Profile List of Johnson & Johnson
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Johnson & Johnson 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Johnson & Johnson 2010-2015
Table SWOT Analysis of Johnson & Johnson 2010-2015
Table Company Profile List of NeoStem Oncology
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of NeoStem Oncology 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of NeoStem Oncology 2010-2015
Table SWOT Analysis of NeoStem Oncology 2010-2015
Table Company Profile List of NewLink Genetics
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of NewLink Genetics 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of NewLink Genetics 2010-2015
Table SWOT Analysis of NewLink Genetics 2010-2015
Table Company Profile List of Northwest Biotherapeutics
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Northwest Biotherapeutics 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Northwest Biotherapeutics 2010-2015
Table SWOT Analysis of Northwest Biotherapeutics 2010-2015
Table Company Profile List of Merck
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Merck 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Merck 2010-2015
Table SWOT Analysis of Merck 2010-2015
Table Company Profile List of Novartis
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Novartis 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Novartis 2010-2015
Table SWOT Analysis of Novartis 2010-2015
Table Company Profile List of Peregrine Pharmaceuticals
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Peregrine Pharmaceuticals 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Peregrine Pharmaceuticals 2010-2015
Table SWOT Analysis of Peregrine Pharmaceuticals 2010-2015
Table Company Profile List of Pfizer
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Pfizer 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Pfizer 2010-2015
Table SWOT Analysis of Pfizer 2010-2015
Table Company Profile List of Roche
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Roche 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Roche 2010-2015
Table SWOT Analysis of Roche 2010-2015
Table Company Profile List of Sanofi
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Sanofi 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Sanofi 2010-2015
Table SWOT Analysis of Sanofi 2010-2015
Table Company Profile List of Seattle Genetics
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Seattle Genetics 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Seattle Genetics 2010-2015
Table SWOT Analysis of Seattle Genetics 2010-2015
Table Company Profile List of Teva
Table Cancer Targeted Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Teva 2010-2015
Figure Cancer Targeted Therapy Revenue and Growth Rate of Teva 2010-2015
Table SWOT Analysis of Teva 2010-2015
Figure Cancer Targeted Therapy Manufactor Profit Model
Figure Marketing Channels Status of Cancer Targeted Therapy
Figure Global Revenue and Growth Rate of Cancer Targeted Therapy 2016-2021
Figure China Revenue and Growth Rate of Cancer Targeted Therapy 2016-2021
Figure Global and China Cancer Targeted Therapy Revenue Comparison 2016-2021
Table Equipment Suppliers of Cancer Targeted Therapy with Contact Information
Table Major Suppliers of Cancer Targeted Therapy with Contact Information
Table Key Consumers of Cancer Targeted Therapy with Contact Information
Figure Supply Chain Relationship Analysis of Cancer Targeted Therapy
Table New Project SWOT Analysis of Cancer Targeted Therapy

Enquiry Before Buy
image
Can´t read the image ? refresh here.